To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Seroprevalences of herpes… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.

Journal article
Authors Staffan Görander
Teresa Lagergård
Malgorzata Romanik
Raphael P Viscidi
Gayane Martirosian
Jan-Åke Liljeqvist
Published in Clinical and vaccine immunology : CVI
Volume 15
Issue 4
Pages 675-80
ISSN 1556-679X
Publication year 2008
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Institute of Biomedicine, Department of Infectious Medicine
Pages 675-80
Language en
Keywords Adult, Chlamydia Infections, blood, epidemiology, microbiology, Chlamydia trachomatis, isolation & purification, Female, Herpes Genitalis, blood, epidemiology, virology, Herpesvirus 2, Human, isolation & purification, Humans, Male, Middle Aged, Papillomaviridae, isolation & purification, Papillomavirus Infections, blood, epidemiology, virology, Poland, epidemiology, Seroepidemiologic Studies
Subject categories Microbiology in the medical area


Herpes simplex virus type 2 (HSV-2), human papillomaviruses (HPVs), and Chlamydia trachomatis are the most common pathogens causing sexually transmitted infections (STIs). There is limited information about the prevalences of these STIs in Poland. Here, we estimated the occurrence of immunoglobulin G (IgG) antibodies against HSV-2, HPV, and C. trachomatis in 199 blood donors and 110 patients of both genders attending an STI clinic in Katowice in southern Poland. The seroprevalences of HSV-2 were 5% for blood donors and 14% in the STI cohort. The seroprevalences of the five potentially oncogenic HPV types 16, 18, 31, 35, and 51 were 15%, 7%, 5%, 5%, and 17%, respectively, in blood donors and 37%, 8%, 12%, 5%, and 21%, respectively, in the STI cohort. The majority of HPV-infected individuals showed antibodies against more than one type, i.e., had been infected with multiple HPV types. Anti-C. trachomatis IgG antibodies were detected in 6% of blood donors and 13% of individuals attending the STI clinic. The relatively high prevalence of HPV-51 may have implications for future vaccine programs, as the newly introduced HPV vaccines are based on the potentially oncogenic HPV types 16 and 18.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?